Loading
Omega Healthcare Investors Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Gupta Vikas, was filed 06 Nov 2025.
Insider Decl.
428
Thresholds
n/a
Buy Volume
€11M
38 ops. · all time
Sell Volume
€45M
61 ops. · all time
Who traded when
BuySaleLisa Egbuonu-Davis2 sales
C. Taylor Pickett1 buy
Vikas Gupta1 buy
Since the insiders bought
- +4.7%Entry US$43.54 · Close at T+90 US$45.57
- +4.7%Entry US$43.54 · Close at T+90 US$45.57
- +2.9%Entry US$29.47 · Close at T+365 US$30.31
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Omega Healthcare Investors Inc Buy (bullish), based on 18 analysts. Average price target: US$51.33.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 6,485 of 26,248 companies
64.4
score / 100
Value53
Quality76
FCF yld6.1%
Earn yld4.0%
EV/EBITDA16.0x
ROE17%
Gross mgn99%
Net mgn48%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$45.55
Analyst consensus
18 analystsBuy
US$45.00Target US$51.33(+13%)US$61.00
Income statement
RevenueUS$1.2B
Gross profitUS$1.2B99% margin
EBITDAUS$1.2B98% margin
Net incomeUS$572M68.1% margin
Valuation
PER (trailing)16.3x
PER (forward)22.5x
P/Book2.5x
Beta0.53
Balance sheet & cash
Market capUS$14.4B
Total debtUS$4.3B
Free Cash FlowUS$878.6M
Debt / Equity71%
Profitability & ownership
ROE16.5%
ROA4.9%
% insiders0.2%
% institutions83.3%
Last declaration on 1 October 2026
Declarations428 total
64 shares@ US$39.370.0000% mcap94.8% of flowCommon StockSEC:0002148932-26-000006:0
3 shares@ US$46.310.0000% mcap5.2% of flowCommon StockSEC:0002148932-26-000006:1
5,131 shares0Common StockSEC:0001873318-26-000004:0
168 sharesCommon StockSEC:0001824484-26-000011:0
11 sharesCommon StockSEC:0001824484-26-000011:1
3,778 shares@ US$43.670.0010% mcap16.5% of flowCommon StockSEC:0001873318-26-000002:0
168 shares@ US$37.254.0% of flowCommon StockSEC:0001824484-26-000009:0
8 shares@ US$43.820.2% of flowCommon StockSEC:0001824484-26-000009:1
31,426 shares0Common StockSEC:0001157251-26-000005:1
31,426 shares0Common StockSEC:0001157251-26-000005:0
12 shares@ US$44.340.3% of flowCommon StockSEC:0001824484-26-000003:1
173 shares@ US$35.894.0% of flowCommon StockSEC:0001824484-26-000003:0
3,850 shares0Common StockSEC:0001157251-26-000002:0
11,500 shares@ US$42.966898.6% of flowCommon StockSEC:0002051514-25-000007:0
Canonical exit: 4 Feb 2026 (T+90)
20,000 shares@ US$43.142898.4% of flowCommon StockSEC:0001143567-25-000007:0
Canonical exit: 3 Feb 2026 (T+90)
17 shares@ US$42.220.4% of flowCommon StockSEC:0001824484-25-000007:1
201 shares@ US$31.164.0% of flowCommon StockSEC:0001824484-25-000007:0
800 shares0Common StockSEC:0001415889-25-023214:0
2,300 shares@ US$40.168.4% of flowCommon StockSEC:0001415889-25-021422:1
200 shares@ US$40.160.8% of flowCommon StockSEC:0001415889-25-021422:0
9 shares@ US$36.650.2% of flowCommon StockSEC:0001415889-25-018672:1
200 shares@ US$31.164.0% of flowCommon StockSEC:0001415889-25-018672:0
4,388 shares@ US$37.6019.0% of flowCommon StockSEC:0001415889-25-016461:0
7,114 shares@ US$37.6020.9% of flowCommon StockSEC:0001415889-25-016458:0
4,388 shares@ US$37.6016.7% of flowCommon StockSEC:0001415889-25-016457:0
25 of 428 declarations
About Omega Healthcare Investors Inc
Bernard J. Korman, Director at Omega Healthcare Investors Inc, filed the three largest purchases in the record: EUR 2,638,150 on November 4, 2016, EUR 2,423,472 on October 31, 2017 and EUR 2,267,795 on December 22, 2017. In total, 38 purchases come to EUR 10.8 million (median EUR 25,013), against 61 sales worth EUR 44.7 million (median EUR 714,552), or 38% purchases among open-market trades.
C. Taylor Pickett, Chief Executive Officer, sold EUR 3,204,863 and EUR 2,114,122 on December 28, 2020; Steven J. Insoft, Chief Corp Development Officer, sold EUR 2,803,610 on April 11, 2017. Robert O. Stephenson, Chief Financial Officer, is the busiest filer with 63 filings. The record also counts 200 grants, 93 option exercises and 36 filings of another kind.
Read moreShow less
The US healthcare real estate company has a market capitalisation of USD 14.4 billion, with 0.2% of the capital in insiders' hands. Its 428 filings, from 23 filers, run from January 5, 2016 to October 1, 2026: 76 in 2016 and 73 in 2020, but 14 in 2022. On November 5, 2025 and November 6, 2025, 2 insiders bought EUR 1,181,043. For 38 purchases a 90-day result is stored: a median of 3%, with 63% of results positive, recorded past results and not a forecast.
